Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.

A. D. Roses, A. M. Saunders, E. H. Corder, Margaret A Pericak-Vance, S. H. Han, G. Einstein, C. Hulette, D. E. Schmechel, M. Holsti, D. Huang

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Apolipoprotein E-epsilon 4 (APOE4, gene; apoE4, protein) is a susceptibility gene or risk factor for Alzheimer's disease. The genetic relevance of APOE4 has been widely confirmed. The APOE gene is not a disease locus, with specific mutations causing Alzheimer disease. Allelic variations at the APOE locus affect the rate of disease progression. The association of specific inherited APOE alleles with age of onset distributions describes biological effects based on genotype. The inheritance of polymorphic genes with single amino acid differences between apoE4 and apoE3 (and between apoE3 and apoE2) at the protein level is associated with differences in the mean age of disease onset spanning almost two decades. The isoform-specific metabolism of apoE resulting in a faster rate of disease expression can now be studied with the expectation that genetically relevant processes are being investigated. There is now an opportunity to develop theories directed at the genetically relevant apoE metabolism that can significantly delay disease expression.

Original languageEnglish
Pages (from-to)413-417
Number of pages5
JournalArzneimittel-Forschung/Drug Research
Volume45
Issue number3 A
StatePublished - Mar 1 1995
Externally publishedYes

Fingerprint

Apolipoprotein E2
Apolipoprotein E4
Apolipoproteins E
Alzheimer Disease
Genes
Apolipoprotein E3
Age of Onset
Age Distribution
Metabolism
Disease Progression
Protein Isoforms
Proteins
Alleles
Genotype
Amino Acids
Mutation

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease. / Roses, A. D.; Saunders, A. M.; Corder, E. H.; Pericak-Vance, Margaret A; Han, S. H.; Einstein, G.; Hulette, C.; Schmechel, D. E.; Holsti, M.; Huang, D.

In: Arzneimittel-Forschung/Drug Research, Vol. 45, No. 3 A, 01.03.1995, p. 413-417.

Research output: Contribution to journalArticle

Roses, AD, Saunders, AM, Corder, EH, Pericak-Vance, MA, Han, SH, Einstein, G, Hulette, C, Schmechel, DE, Holsti, M & Huang, D 1995, 'Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.', Arzneimittel-Forschung/Drug Research, vol. 45, no. 3 A, pp. 413-417.
Roses, A. D. ; Saunders, A. M. ; Corder, E. H. ; Pericak-Vance, Margaret A ; Han, S. H. ; Einstein, G. ; Hulette, C. ; Schmechel, D. E. ; Holsti, M. ; Huang, D. / Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease. In: Arzneimittel-Forschung/Drug Research. 1995 ; Vol. 45, No. 3 A. pp. 413-417.
@article{1445b218164f4225ba4cb52bb1e444f7,
title = "Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.",
abstract = "Apolipoprotein E-epsilon 4 (APOE4, gene; apoE4, protein) is a susceptibility gene or risk factor for Alzheimer's disease. The genetic relevance of APOE4 has been widely confirmed. The APOE gene is not a disease locus, with specific mutations causing Alzheimer disease. Allelic variations at the APOE locus affect the rate of disease progression. The association of specific inherited APOE alleles with age of onset distributions describes biological effects based on genotype. The inheritance of polymorphic genes with single amino acid differences between apoE4 and apoE3 (and between apoE3 and apoE2) at the protein level is associated with differences in the mean age of disease onset spanning almost two decades. The isoform-specific metabolism of apoE resulting in a faster rate of disease expression can now be studied with the expectation that genetically relevant processes are being investigated. There is now an opportunity to develop theories directed at the genetically relevant apoE metabolism that can significantly delay disease expression.",
author = "Roses, {A. D.} and Saunders, {A. M.} and Corder, {E. H.} and Pericak-Vance, {Margaret A} and Han, {S. H.} and G. Einstein and C. Hulette and Schmechel, {D. E.} and M. Holsti and D. Huang",
year = "1995",
month = "3",
day = "1",
language = "English",
volume = "45",
pages = "413--417",
journal = "Drug Research",
issn = "2194-9379",
publisher = "Thieme",
number = "3 A",

}

TY - JOUR

T1 - Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.

AU - Roses, A. D.

AU - Saunders, A. M.

AU - Corder, E. H.

AU - Pericak-Vance, Margaret A

AU - Han, S. H.

AU - Einstein, G.

AU - Hulette, C.

AU - Schmechel, D. E.

AU - Holsti, M.

AU - Huang, D.

PY - 1995/3/1

Y1 - 1995/3/1

N2 - Apolipoprotein E-epsilon 4 (APOE4, gene; apoE4, protein) is a susceptibility gene or risk factor for Alzheimer's disease. The genetic relevance of APOE4 has been widely confirmed. The APOE gene is not a disease locus, with specific mutations causing Alzheimer disease. Allelic variations at the APOE locus affect the rate of disease progression. The association of specific inherited APOE alleles with age of onset distributions describes biological effects based on genotype. The inheritance of polymorphic genes with single amino acid differences between apoE4 and apoE3 (and between apoE3 and apoE2) at the protein level is associated with differences in the mean age of disease onset spanning almost two decades. The isoform-specific metabolism of apoE resulting in a faster rate of disease expression can now be studied with the expectation that genetically relevant processes are being investigated. There is now an opportunity to develop theories directed at the genetically relevant apoE metabolism that can significantly delay disease expression.

AB - Apolipoprotein E-epsilon 4 (APOE4, gene; apoE4, protein) is a susceptibility gene or risk factor for Alzheimer's disease. The genetic relevance of APOE4 has been widely confirmed. The APOE gene is not a disease locus, with specific mutations causing Alzheimer disease. Allelic variations at the APOE locus affect the rate of disease progression. The association of specific inherited APOE alleles with age of onset distributions describes biological effects based on genotype. The inheritance of polymorphic genes with single amino acid differences between apoE4 and apoE3 (and between apoE3 and apoE2) at the protein level is associated with differences in the mean age of disease onset spanning almost two decades. The isoform-specific metabolism of apoE resulting in a faster rate of disease expression can now be studied with the expectation that genetically relevant processes are being investigated. There is now an opportunity to develop theories directed at the genetically relevant apoE metabolism that can significantly delay disease expression.

UR - http://www.scopus.com/inward/record.url?scp=0029263413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029263413&partnerID=8YFLogxK

M3 - Article

C2 - 7763336

AN - SCOPUS:0029263413

VL - 45

SP - 413

EP - 417

JO - Drug Research

JF - Drug Research

SN - 2194-9379

IS - 3 A

ER -